Annual CFF
-$16.16 M
-$31.03 M-208.62%
December 31, 2023
Summary
- As of March 11, 2025, FNCH annual cash flow from financing activities is -$16.16 million, with the most recent change of -$31.03 million (-208.62%) on December 31, 2023.
- During the last 3 years, FNCH annual CFF has fallen by -$107.63 million (-117.66%).
- FNCH annual CFF is now -113.56% below its all-time high of $119.11 million, reached on December 31, 2021.
Performance
FNCH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
June 30, 2024
Summary
- As of March 11, 2025, FNCH quarterly cash flow from financing activities is $0.00, unchanged on June 30, 2024.
- Over the past year, FNCH quarterly CFF has stayed the same.
- FNCH quarterly CFF is now -100.00% below its all-time high of $117.37 million, reached on March 31, 2021.
Performance
FNCH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$0.00
-$4000.00-100.00%
June 30, 2024
Summary
- As of March 11, 2025, FNCH TTM cash flow from financing activities is $0.00, with the most recent change of -$4000.00 (-100.00%) on June 30, 2024.
- Over the past year, FNCH TTM CFF has stayed the same.
- FNCH TTM CFF is now -100.00% below its all-time high of $208.85 million, reached on March 31, 2021.
Performance
FNCH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FNCH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -208.6% | 0.0% | 0.0% |
| 3 y3 years | -117.7% | 0.0% | 0.0% |
| 5 y5 years | -130.3% | 0.0% | 0.0% |
FNCH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -113.6% | at low | -100.0% | +100.0% | -100.0% | +100.0% |
| 5 y | 5-year | -113.6% | at low | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -113.6% | at low | -100.0% | +100.0% | -100.0% | +100.0% |
Finch Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $4000.00(-100.0%) |
| Dec 2023 | -$16.16 M(-208.6%) | $0.00(0.0%) | -$16.16 M(+0.3%) |
| Sep 2023 | - | $0.00(-100.0%) | -$16.10 M(+0.3%) |
| Jun 2023 | - | $4000.00(-100.0%) | -$16.06 M(+1144.2%) |
| Mar 2023 | - | -$16.16 M(<-9900.0%) | -$1.29 M(-108.7%) |
| Dec 2022 | $14.87 M | $52.00 K(+26.8%) | $14.87 M(-0.1%) |
| Sep 2022 | - | $41.00 K(-99.7%) | $14.89 M(-0.0%) |
| Jun 2022 | - | $14.78 M(>+9900.0%) | $14.89 M(+752.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $5000.00(-92.9%) | $1.75 M(-98.5%) |
| Dec 2021 | $119.11 M(+30.2%) | $70.00 K(+55.6%) | $119.11 M(+0.3%) |
| Sep 2021 | - | $45.00 K(-97.2%) | $118.81 M(-43.1%) |
| Jun 2021 | - | $1.63 M(-98.6%) | $208.67 M(-0.1%) |
| Mar 2021 | - | $117.37 M(<-9900.0%) | $208.85 M(+128.3%) |
| Dec 2020 | $91.47 M(+71.6%) | -$229.00 K(-100.3%) | $91.47 M(-0.2%) |
| Sep 2020 | - | $89.91 M(+4886.4%) | $91.70 M(+4997.5%) |
| Jun 2020 | - | $1.80 M(<-9900.0%) | $1.80 M(<-9900.0%) |
| Mar 2020 | - | -$4000.00 | -$4000.00 |
| Dec 2019 | $53.30 M | - | - |
FAQ
- What is Finch Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Finch Therapeutics?
- What is Finch Therapeutics annual CFF year-on-year change?
- What is Finch Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Finch Therapeutics?
- What is Finch Therapeutics quarterly CFF year-on-year change?
- What is Finch Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Finch Therapeutics?
- What is Finch Therapeutics TTM CFF year-on-year change?
What is Finch Therapeutics annual cash flow from financing activities?
The current annual CFF of FNCH is -$16.16 M
What is the all time high annual CFF for Finch Therapeutics?
Finch Therapeutics all-time high annual cash flow from financing activities is $119.11 M
What is Finch Therapeutics annual CFF year-on-year change?
Over the past year, FNCH annual cash flow from financing activities has changed by -$31.03 M (-208.62%)
What is Finch Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of FNCH is $0.00
What is the all time high quarterly CFF for Finch Therapeutics?
Finch Therapeutics all-time high quarterly cash flow from financing activities is $117.37 M
What is Finch Therapeutics quarterly CFF year-on-year change?
Over the past year, FNCH quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Finch Therapeutics TTM cash flow from financing activities?
The current TTM CFF of FNCH is $0.00
What is the all time high TTM CFF for Finch Therapeutics?
Finch Therapeutics all-time high TTM cash flow from financing activities is $208.85 M
What is Finch Therapeutics TTM CFF year-on-year change?
Over the past year, FNCH TTM cash flow from financing activities has changed by $0.00 (0.00%)